摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-methyl-1H-pyrazol-1-yl)phenol | 83430-98-2

中文名称
——
中文别名
——
英文名称
2-(3-methyl-1H-pyrazol-1-yl)phenol
英文别名
2-(3-methylpyrazol-1-yl)phenol
2-(3-methyl-1H-pyrazol-1-yl)phenol化学式
CAS
83430-98-2
化学式
C10H10N2O
mdl
——
分子量
174.202
InChiKey
YSAACJNGJBVKKY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    302.3±25.0 °C(Predicted)
  • 密度:
    1.17±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    38
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    2,4-ditert-butyl-6-(3-methylpyrazol-1-yl)phenol磷酸 作用下, 反应 4.0h, 以85%的产率得到2-(3-methyl-1H-pyrazol-1-yl)phenol
    参考文献:
    名称:
    Fukata, Guouki; Itoh, Takashi; Tashiro, Masashi, Heterocycles, 1982, vol. 19, # 8, p. 1487 - 1495
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Biaryloxymethylarenecarboxylic acids as glycogen synthase activators
    申请人:Gillespie Paul
    公开号:US20060122256A1
    公开(公告)日:2006-06-08
    The present invention relates to compounds of formula (I) wherein Ar, Ar 2 , R 2 , R 3 , R 4 , m, p and s are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases that are associated with the activation of the glycogen synthase enzyme, such as diabetes.
    本发明涉及以下式(I)的化合物,其中Ar、Ar2、R2、R3、R4、m、p和s如描述和索赔中所定义,并且其药学上可接受的盐。这些化合物可用于治疗和/或预防与糖原合成酶激活相关的疾病,如糖尿病。
  • BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS
    申请人:Gillespie Paul
    公开号:US20090156635A1
    公开(公告)日:2009-06-18
    The present invention relates to compounds of formula (I) wherein Ar, Ar 2 , R 2 , R 3 , R 4 , m, p and s are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases that are associated with the activation of the glycogen synthase enzyme, such as diabetes.
    本发明涉及式(I)化合物,其中Ar,Ar2,R2,R3,R4,m,p和s如描述和权利要求中所定义,以及其药学上可接受的盐。该化合物可用于治疗和/或预防与糖原合成酶酶活化有关的疾病,例如糖尿病。
  • NITROGENOUS HETEROCYCLIC AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION THEREOF
    申请人:Shanghai Yingli Pharmaceutical Co. Ltd.
    公开号:EP3492461A1
    公开(公告)日:2019-06-05
    Provided are a nitrogenous heterocyclic aromatic compound, a preparation method therefor, a pharmaceutical composition thereof, and an application thereof. The nitrogenous heterocyclic aromatic compound can be used for treating and/or preventing various diseases mediated by ALK5.
    本文提供了一种含氮杂环芳香化合物、其制备方法、药物组合物及其应用。该含氮杂环芳香化合物可用于治疗和/或预防由 ALK5 介导的各种疾病。
  • Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereof
    申请人:SHANGHAI YINGLI PHARMACEUTICAL CO., LTD
    公开号:US11466003B2
    公开(公告)日:2022-10-11
    Provided are a nitrogenous heterocyclic aromatic compound, a preparation method therefor, a pharmaceutical composition thereof, and an application thereof. The nitrogenous heterocyclic aromatic compound can be used for treating and/or preventing various diseases mediated by ALK5.
    本文提供了一种含氮杂环芳香化合物、其制备方法、药物组合物及其应用。该含氮杂环芳香化合物可用于治疗和/或预防由 ALK5 介导的各种疾病。
  • Method for producing a heterocyclic compound and an aromatic carboxylic acid having one or more hydroxyl groups, and modified aromatic ring dioxygenase
    申请人:——
    公开号:US20040086983A1
    公开(公告)日:2004-05-06
    An objective of the present invention is to provide a method of producing hydroxylated heterocyclic compounds and hydroxylated aromatic carboxylic acids by bioengineering technique, and modified enzymes which can be used for this method. A method of producing hydroxylated heterocyclic compounds or hydroxylated aromatic carboxylic acids comprises reacting an aromatic ring dioxygenase with heterocyclic compounds or aromatic carboxylic acids to hydroxylate these compounds. An enzyme according to the present invention is an aromatic ring dioxygenase comprising an &agr;-subunit consisting of the amino acid sequence of SEQ ID NO: 2, which is modified according to the &agr;-subunit of the biphenyl dioxygenase derived from the strain Burkholderia cepacia LB400, a &bgr;-subunit consisting of the amino acid sequence of SEQ ID NO: 4, and a ferredoxin consisting of the amino acid sequence of SEQ ID NO: 6, and a ferredoxin reductase consisting of the amino acid sequence of SEQ ID NO: 8.
    本发明的目的是提供一种通过生物工程技术生产羟基化杂环化合物和羟基化芳香族羧酸的方法,以及可用于该方法的改良酶。生产羟基化杂环化合物或羟基化芳香族羧酸的方法包括使芳香环二加氧酶与杂环化合物或芳香族羧酸反应,使这些化合物羟基化。根据本发明的一种酶是一种芳香环二加氧酶,它包括一个由 SEQ ID NO: 2 的氨基酸序列组成的&agr;-亚基,它是根据从菌株中得到的联苯二加氧酶的&agr;-亚基修饰的 伯克霍尔德氏菌 LB400,由 SEQ ID NO: 4 的氨基酸序列组成的&bgr;-亚基,由 SEQ ID NO: 6 的氨基酸序列组成的毒素,以及由 SEQ ID NO: 8 的氨基酸序列组成的毒素还原酶。
查看更多